Thursday, August 13, 2015

Intralesional therapy for melanoma

100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: Results of a case series

In this article we report the results of 11 melanoma patients treated with intralesional IL-2 with imiquimod for in-transit mets.The combination therapy worked very well.  Link to Article